London Company of Virginia’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
|
|||||
|
2025
Q1 | $1.93M | Sell |
|
|||||
|
2024
Q4 | $2.91M | Sell |
|
|||||
|
2024
Q3 | $30.1M | Sell |
|
|||||
|
2024
Q2 | $30M | Sell |
|
|||||
|
2024
Q1 | $31.3M | Buy |
|
|||||
|
2023
Q4 | $28M | Sell |
|
|||||
|
2023
Q3 | $91.5M | Sell |
|
|||||
|
2023
Q2 | $267M | Sell |
|
|||||
|
2023
Q1 | $304M | Sell |
|
|||||
|
2022
Q4 | $392M | Buy |
|
|||||
|
2022
Q3 | $335M | Buy |
|
|||||
|
2022
Q2 | $391M | Sell |
|
|||||
|
2022
Q1 | $398M | Buy |
|
|||||
|
2021
Q4 | $439M | Buy |
|
|||||
|
2021
Q3 | $319M | Buy |
|
|||||
|
2021
Q2 | $284M | Buy |
|
|||||
|
2021
Q1 | $261M | Sell |
|
|||||
|
2020
Q4 | $265M | Sell |
|
|||||
|
2020
Q3 | $261M | Buy |
|
|||||
|
2020
Q2 | $232M | Buy |
|
|||||
|
2020
Q1 | $226M | Sell |
|
|||||
|
2019
Q4 | $283M | Sell |
|
|||||
|
2019
Q3 | $265M | Buy |
|
|||||
|
2019
Q2 | $214M | Buy |
|
|||||
|
2019
Q1 | $209M | Sell |
|
|||||
|
2018
Q4 | $218M | Sell |
|
|||||
|
2018
Q3 | $237M | Sell |
|
|||||
|
2018
Q2 | $199M | Sell |
|
|||||
|
2018
Q1 | $198M | Sell |
|
|||||
|
2017
Q4 | $228M | Sell |
|
|||||
|
2017
Q3 | $244M | Sell |
|
|||||
|
2017
Q2 | $235M | Buy |
|
|||||
|
2017
Q1 | $238M | Buy |
|
|||||
|
2016
Q4 | $216M | Buy |
|
|||||
|
2016
Q3 | $197M | Buy |
|
|||||
|
2016
Q2 | $190M | Buy |
|
|||||
|
2016
Q1 | $154M | Sell |
|
|||||
|
2015
Q4 | $190M | Buy |
|
|||||
|
2015
Q3 | $164M | Buy |
|
|||||
|
2015
Q2 | $167M | Buy |
|
|||||
|
2015
Q1 | $149M | Buy |
|
|||||
|
2014
Q4 | $114M | Buy |
|
|||||
|
2014
Q3 | $95.5M | Buy |
|
|||||
|
2014
Q2 | $91.4M | Buy |
|
|||||
|
2014
Q1 | $89.6M | Buy |
|
|||||
|
2013
Q4 | $81.8M | Buy |
|
|||||
|
2013
Q3 | $63.7M | Buy |
|
|||||
|
2013
Q2 | $57.3M | Buy |
|